Osmotica Pharmaceutical Appoints Praveen Tyle, Ph.D. as President and CEO
1/4/2013 7:07:32 AM
More...
|
Osmotica Pharmaceutical Announces Initiation of Phase III Studies With Arbaclofen ER Tablets
12/10/2012 9:41:50 AM
More...
|
Osmotica Pharmaceutical Announces the Appointment of Praveen Tyle, PhD as Executive Vice President and Chief Scientific Officer
10/15/2012 10:17:24 AM
More...
|
Osmotica Pharmaceutical and Panacea Biotech Ltd. Announce Strategic Alliance Agreement
9/11/2012 10:15:30 AM
More...
|
Osmotica Pharmaceutical Announces the Appointment of Darren Alkins as Executive Vice President
9/10/2012 9:34:04 AM
More...
|
Osmotica Pharmaceutical to Create 156 Jobs in Georgia
8/12/2011 7:39:36 AM
More...
|
Osmotica Pharmaceutical and Upstate Pharma, LLC, a Subsidiary of UCB, Inc. (UCBJF.PK), Announce the Availability of Venlafaxine Extended-Release Tablets
10/9/2008 11:08:15 AM
More...
|
Osmotica Pharmaceutical Announces The Successful Co-Development Of FDA-Approved Allegra-D 24-Hour Extended Release Tablets
10/19/2005 5:12:03 PM
More...
|
New Drug Application Approved For Once-Daily Allegra-D Formulation Using aaiPharma Inc.'s (AAII) Development Expertise
10/19/2005 5:11:57 PM
More...
|
Osmotica Pharmaceutical To Move To Boca Raton
10/19/2005 5:09:10 PM
More...
|